Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones
- 1 February 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (3) , 443-448
- https://doi.org/10.1016/s0960-894x(99)00004-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Inhibition of human cytomegalovirus protease No with monocyclic β-lactamsBioorganic & Medicinal Chemistry Letters, 1998
- Design and synthesis of monocyclic β-lactams as mechanism-based inhibitors of human cytomegalovirus proteaseBioorganic & Medicinal Chemistry Letters, 1998
- Potent selective thienoxazinone inhibitors of herpes proteasesBioorganic & Medicinal Chemistry Letters, 1997
- Inhibition of HSV-1 protease by benzoxazinonesBioorganic & Medicinal Chemistry Letters, 1996
- Novel, selective mechanism-based inhibitors of the herpes proteasesBioorganic & Medicinal Chemistry Letters, 1996
- Structure of the Human Cytomegalovirus Protease Catalytic Domain Reveals a Novel Serine Protease Fold and Catalytic TriadCell, 1996
- Unique fold and active site in cytomegalovirus proteaseNature, 1996
- A new serine-protease fold revealed by the crystal structure of human cytomegalovirus proteaseNature, 1996
- Three-dimensional structure of human cytomegalovirus proteaseNature, 1996
- The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrateJournal of Virology, 1991